ANI Pharma Seeks Green Light for Controlled Drug Imports
Published Date: 6/2/2025
Notice
Summary
ANI Pharmaceuticals Inc wants to get official permission to bring in certain controlled drugs to the U.S. This means they’ll be able to import important medicines that need special handling. If approved, it could affect drug availability and timing, but no cost changes are mentioned yet.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Application to Import Controlled Medicines
ANI Pharmaceuticals Inc has applied to be registered as an importer of basic class(es) of controlled substances. If the registration is approved, it could affect the availability and timing of those controlled medicines in the U.S., and the notice states that no changes to costs are mentioned.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in